Tradestie Institutional Equity Comparison Engine
FNCL vs FHLC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
FHLC Overall Edge
FHLC Captures Institutional Edge (2โ0 Pillars ยท 1โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Fidelity MSCI Health Care Index ETF (FHLC) driven by superior Momentum & Technical, Options & Structure. Fundamentally, FNCL trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus FHLC at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, FNCL sits in UNCLASSIFIED (5th %ile IV; Dealer Gamma Walls on Pro) against FHLC sits in UNCLASSIFIED (1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
FNCL N/M vs FHLC N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
FHLC
1Y +9.2% vs +22.3% ยท 52W Pos 84% vs 90%
Options & Structure Winner
FHLC
UNCLASSIFIED (5th %ile IV) vs UNCLASSIFIED (1st %ile IV)
FNCL
NYSE Arca
Fidelity MSCI Financials Index ETF
Institutional Equity
$81.81
-0.85% 1D
Market Cap
N/A
1M Return
+4.3%
1Y Return
+9.15%
Forward P/E
N/M
Unified AI Score
47.3 / 100
HOLD
Tech 42.0
Fund 44.0
Flow 50.0
Mom 31.1
FHLC
NYSE Arca
Fidelity MSCI Health Care Index ETF
Institutional Equity
$89.37
-0.7% 1D
Market Cap
N/A
1M Return
+5.7%
1Y Return
+22.29%
Forward P/E
N/M
Unified AI Score
41.6 / 100
SELL
Tech 27.0
Fund 33.0
Flow 50.0
Mom 21.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
FNCL +9.15%
FHLC +22.29%
Spread: +13.14 pp (FHLC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
FNCL TTM Op. Margin: N/A
FHLC TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FNCL vs FHLC. Trailing 12-month operating profitability (FNCL N/A vs FHLC N/A) and valuation multiples (FNCL N/M vs FHLC N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FNCL | FHLC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 84% ($68โ$85) | 90% ($68โ$92) | Stronger Trend | FHLC |
| Beta / 30D Volatility Risk Regime | 0.53ฮฒ ยท 21% Vol | 0.36ฮฒ ยท 21% Vol | Lower Realized Risk | Tie |
| Unified Institutional Score Composite Signal | 47.3 / 100 (HOLD) | 41.6 / 100 (SELL) | Higher Composite | FNCL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full FNCL vs FHLC Buy Guide
FNCL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
FHLC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither FNCL nor FHLC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.